See the DrugPatentWatch profile for Eluxadoline
What is eluxadoline, and how is it used for IBS?
Eluxadoline (brand name Viberzi) is a prescription medicine for adults with irritable bowel syndrome with diarrhea (IBS-D). It works in the gut to reduce diarrhea and abdominal pain by acting on opioid receptors in the gastrointestinal tract.[1]
IBS-D vs IBS-C: does eluxadoline work for constipation-type IBS?
Eluxadoline is specifically indicated for IBS with diarrhea (IBS-D), not for constipation-type IBS (IBS-C). Patients with IBS-C generally need different treatment options.[1]
How does eluxadoline help IBS symptoms?
By targeting opioid receptors in the gastrointestinal tract, eluxadoline reduces bowel frequency and improves related discomfort in IBS-D. Patients typically look for less urgent stools/diarrhea and less abdominal pain.[1]
Who should not take eluxadoline? (important safety limits)
Eluxadoline has important restrictions because it can cause serious side effects in certain people. In particular, it is not recommended for some patients with:
- Severe liver problems
- No gallbladder (or history of gallbladder removal)
- A history of pancreatitis, or other pancreatitis risk factors
- Alcohol misuse or certain heavy alcohol use patterns
These contraindications/limitations are part of why prescribers screen patients carefully before starting therapy.[1]
What are patients commonly worried about?
People starting eluxadoline for IBS-D usually ask about diarrhea improvement and whether it can also affect abdominal pain. They also commonly ask about safety concerns because the drug has specific contraindications (especially related to liver function, gallbladder status, and pancreatitis risk).[1]
What happens if you have IBS and then your symptoms change?
Eluxadoline is meant for IBS-D. If symptoms shift toward constipation or if diarrhea doesn’t improve, clinicians may reassess diagnosis and consider alternatives rather than continuing an IBS-D–targeted therapy.[1]
Related: patents and availability
If you are researching eluxadoline’s market history, exclusivity, or patent status, DrugPatentWatch.com tracks patent and related filings for branded products like Viberzi.[2]
---
Sources
[1] https://www.drugs.com/viberzi.html
[2] https://www.drugpatentwatch.com/